These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7585041)

  • 61. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.
    Wachtel H
    Neuropharmacology; 1983 Mar; 22(3):267-72. PubMed ID: 6302550
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
    Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
    Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of a selective phosphodiesterase inhibitor, rolipram, on muricide in olfactory bulbectomized rats.
    Mizokawa T; Kimura K; Ikoma Y; Hara K; Oshino N; Yamamoto T; Ueki S
    Jpn J Pharmacol; 1988 Nov; 48(3):357-64. PubMed ID: 2906101
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Synthesis of tumour necrosis factor-alpha in tissue culture of rat caecum: lack of suppression by phosphodiesterase inhibitors and prostanoids.
    Greten TF; Moeller J; Feldmeier H; Eigler A; Endres S
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):679-84. PubMed ID: 8853258
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decreased production of TNF-alpha by lymph node cells indicates experimental autoimmune encephalomyelitis remission in Lewis rats.
    Seger J; Zorzella-Pezavento SF; Pelizon AC; Martins DR; Domingues A; Sartori A
    Mem Inst Oswaldo Cruz; 2010 May; 105(3):263-8. PubMed ID: 20512238
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Rolipram as a discriminative stimuli: transfer to phosphodiesterase inhibitors.
    Yamamoto T; Miyamoto K; Ueki S
    Jpn J Pharmacol; 1987 Feb; 43(2):165-71. PubMed ID: 3573424
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
    Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rolipram, a selective phosphodiesterase type-IV inhibitor, prevents induction of heat shock protein HSP-70 and hsp-70 mRNA in rat retrosplenial cortex by the NMDA receptor antagonist dizocilpine.
    Hashimoto K; Tomitaka S; Bi Y; Narita N; Minabe Y; Iyo M
    Eur J Neurosci; 1997 Sep; 9(9):1891-901. PubMed ID: 9383212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
    Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
    Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Methylthioadenosine reverses brain autoimmune disease.
    Moreno B; Hevia H; Santamaria M; Sepulcre J; Muñoz J; García-Trevijano ER; Berasain C; Corrales FJ; Avila MA; Villoslada P
    Ann Neurol; 2006 Sep; 60(3):323-34. PubMed ID: 16786535
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity.
    Sullivan GW; Carper HT; Mandell GL
    Int J Immunopharmacol; 1995 Oct; 17(10):793-803. PubMed ID: 8707444
    [TBL] [Abstract][Full Text] [Related]  

  • 74. LF 15-0195 treatment protects against central nervous system autoimmunity by favoring the development of Foxp3-expressing regulatory CD4 T cells.
    Duplan V; Beriou G; Heslan JM; Bruand C; Dutartre P; Mars LT; Liblau RS; Cuturi MC; Saoudi A
    J Immunol; 2006 Jan; 176(2):839-47. PubMed ID: 16393967
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor rolipram.
    Schneider HH; Yamaguchi M; Andrews JS; Stephens DN
    Pharmacol Biochem Behav; 1995 Feb; 50(2):211-7. PubMed ID: 7740060
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synovial fluid levels of tumor necrosis factor-alpha in the inflamed rat knee: modulation by dexamethasone and inhibitors of matrix metalloproteinase and phosphodiesterase.
    Singh HN; Blancuzzi V; Greenwood S; Skiles JW; O'Byrne EM
    Inflamm Res; 1997 Aug; 46 Suppl 2():S153-4. PubMed ID: 9297557
    [No Abstract]   [Full Text] [Related]  

  • 77. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K; Burke-Gaffney A; Hellewell PG
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rolipram, a stereospecific inhibitor of calmodulin-independent phosphodiesterase, causes beta-adrenoceptor subsensitivity in rat cerebral cortex.
    Schultz JE; Schmidt BH
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):23-30. PubMed ID: 3016560
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats.
    Xu L; Huang Y; Yang J; Van Der Meide PH; Levi M; Wahren B; Link H; Xiao B
    Clin Exp Immunol; 1999 Oct; 118(1):115-21. PubMed ID: 10540168
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis.
    Wildbaum G; Youssef S; Grabie N; Karin N
    J Immunol; 1998 Dec; 161(11):6368-74. PubMed ID: 9834127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.